Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perampanel in Refractory Partial Seizures (OLE)
NCT00735397Phase 3Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Oct 2008
- Primary completion
- Sep 2014
- Modality
- Classical Binding Small Molecules
- Countries
- 39
01
Overview
A Phase 3 trial of perampanel in focal-onset epileptic seizures, sponsored by Eisai Co., Ltd.. Started Oct 2008; status: completed.
02
Drugs
perampanel
03
Conditions
focal-onset epileptic seizures
Beyond the preview
Go deeper on NCT00735397.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00735397.